Reta GLP 3 For Sale

This vial contains Reta, a novel “triple agonist” peptide that targets GLP-1, GIP, and glucagon receptors. This peptide is frequently used in research to analyze complex metabolic regulation, fatty liver disease (hepatosteatosis), and energy homeostasis.

Chemical profile

This product is a high-purity (>99%) lyophilized (freeze-dried) powder that requires reconstitution. It is intended for laboratory processing and experimental analysis only.

• Ingredient: Reta (GGG Tri-Agonist)

• Total Amount: [5 mg or 10 mg]

• Purity: >99% (Determined by HPLC)

Quality assurance

• HPLC analysis: Confirmed purity >99%.

• Mass spectrometry: Confirmed molecular weight and structure.

• Toxicity: Not tested for human safety.

Research Context (Literature Review) Reta GLP 3

Note: The following information is for educational purposes regarding the chemical properties of these peptides and does not constitute a medical claim.

Retatrutide represents a new generation of compounds for metabolic research. Unlike single or dual agonists, it activates three receptors: the GLP-1 receptor (insulin secretion), the GIP receptor (lipid metabolism), and the GCGR (glucagon) receptor (energy expenditure).

In preclinical models, glucagon receptor agonism has been observed to increase resting energy expenditure and improve markers of hepatic steatosis. Research is focusing on how this triple mechanism can significantly alter metabolic parameters and body composition in obese rodent models.

Technical specifications Reta GLP 3